These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 34261860

  • 1. P-selectin expression assay in a repeatedly serotonin-release assay-negative patient with heparin-induced thrombocytopenia.
    Arora K, Rodgers S, Alkhatib Y, Onwubiko IN, Padmanabhan A, Otrock ZK.
    Blood Coagul Fibrinolysis; 2021 Oct 01; 32(7):522-525. PubMed ID: 34261860
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A Platelet Factor 4-Dependent Platelet Activation Assay Facilitates Early Detection of Pathogenic Heparin-Induced Thrombocytopenia Antibodies.
    Jones CG, Pechauer SM, Curtis BR, Bougie DW, Irani MS, Dhakal B, Pierce B, Aster RH, Padmanabhan A.
    Chest; 2017 Oct 01; 152(4):e77-e80. PubMed ID: 28991552
    [Abstract] [Full Text] [Related]

  • 5. Beneficial effect of exogenous platelet factor 4 for detecting pathogenic heparin-induced thrombocytopenia antibodies.
    Vayne C, Guery EA, Kizlik-Masson C, Rollin J, Bauters A, Gruel Y, Pouplard C.
    Br J Haematol; 2017 Dec 01; 179(5):811-819. PubMed ID: 29048130
    [Abstract] [Full Text] [Related]

  • 6. Distinguishing between anti-platelet factor 4/heparin antibodies that can and cannot cause heparin-induced thrombocytopenia.
    Nazi I, Arnold DM, Warkentin TE, Smith JW, Staibano P, Kelton JG.
    J Thromb Haemost; 2015 Oct 01; 13(10):1900-7. PubMed ID: 26291604
    [Abstract] [Full Text] [Related]

  • 7. Platelet-Activating Antibodies Are Detectable at the Earliest Onset of Heparin-Induced Thrombocytopenia, With Implications for the Operating Characteristics of the Serotonin-Release Assay.
    Warkentin TE, Arnold DM, Kelton JG, Sheppard JI, Smith JW, Nazy I.
    Chest; 2018 Jun 01; 153(6):1396-1404. PubMed ID: 29325985
    [Abstract] [Full Text] [Related]

  • 8. Dimeric FcγR ectodomains detect pathogenic anti-platelet factor 4-heparin antibodies in heparin-induced thromobocytopenia.
    Wines BD, Tan CW, Duncan E, McRae S, Baker RI, Andrews RK, Esparon S, Gardiner EE, Hogarth PM.
    J Thromb Haemost; 2018 Dec 01; 16(12):2520-2525. PubMed ID: 30269432
    [Abstract] [Full Text] [Related]

  • 9. A diagnosis of heparin-induced thrombocytopenia with combined clinical and laboratory methods in cardiothoracic surgical intensive care unit patients.
    Demma LJ, Winkler AM, Levy JH.
    Anesth Analg; 2011 Oct 01; 113(4):697-702. PubMed ID: 21788317
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Serotonin-release assay-negative heparin-induced thrombocytopenia.
    Warkentin TE, Nazy I, Sheppard JI, Smith JW, Kelton JG, Arnold DM.
    Am J Hematol; 2020 Jan 01; 95(1):38-47. PubMed ID: 31621093
    [Abstract] [Full Text] [Related]

  • 12. A comparative study of platelet factor 4-enhanced platelet activation assays for the diagnosis of heparin-induced thrombocytopenia.
    Rubino JG, Arnold DM, Warkentin TE, Smith JW, Kelton JG, Nazy I.
    J Thromb Haemost; 2021 Apr 01; 19(4):1096-1102. PubMed ID: 33387395
    [Abstract] [Full Text] [Related]

  • 13. Comparison of two PF4/heparin ELISA assays for the laboratory diagnosis of heparin-induced thrombocytopenia.
    Izban KF, Lietz HW, Hoppensteadt DA, Jeske WP, Fareed J, Bakhos M, Walenga JM.
    Semin Thromb Hemost; 1999 Apr 01; 25 Suppl 1():51-6. PubMed ID: 10357152
    [Abstract] [Full Text] [Related]

  • 14. Prevalence, isotype, and functionality of antiheparin-platelet factor 4 antibodies in patients treated with heparin and clinically suspected for heparin-induced thrombocytopenia. The pathogenic role of IgG.
    Untch B, Ahmad S, Jeske WP, Messmore HL, Hoppensteadt DA, Walenga JM, Lietz H, Fareed J.
    Thromb Res; 2002 Jan 15; 105(2):117-23. PubMed ID: 11958801
    [Abstract] [Full Text] [Related]

  • 15. Clinical effectiveness of a Bayesian algorithm for the diagnosis and management of heparin-induced thrombocytopenia.
    Raschke RA, Gallo T, Curry SC, Whiting T, Padilla-Jones A, Warkentin TE, Puri A.
    J Thromb Haemost; 2017 Aug 15; 15(8):1640-1645. PubMed ID: 28622439
    [Abstract] [Full Text] [Related]

  • 16. Performance evaluation of heparin-induced platelet aggregation vs serotonin release assay.
    Barouqa M, Matta M, Reyes-Gil M.
    Am J Clin Pathol; 2024 Feb 01; 161(2):122-129. PubMed ID: 37936260
    [Abstract] [Full Text] [Related]

  • 17. Determination of heparin-induced thrombocytopenia: a rapid flow cytometric assay for direct demonstration of antibody-mediated platelet activation.
    Tomer A, Masalunga C, Abshire TC.
    Am J Hematol; 1999 May 01; 61(1):53-61. PubMed ID: 10331512
    [Abstract] [Full Text] [Related]

  • 18. Using novel PF4-dependent P-selectin expression assay to diagnose heparin-induced thrombocytopaenia postliver transplantation.
    Tchen S, Bhatt R, Rezazadeh A, Foy P.
    BMJ Case Rep; 2022 Jun 09; 15(6):. PubMed ID: 35680283
    [Abstract] [Full Text] [Related]

  • 19. Serologic results in >1000 patients with suspected heparin-induced thrombocytopenia.
    Shelat SG, Tomaski A, Pollak ES.
    Clin Appl Thromb Hemost; 2008 Oct 09; 14(4):410-4. PubMed ID: 17895512
    [Abstract] [Full Text] [Related]

  • 20. Variable serotonin release assay pattern and specificity of PF4-specific antibodies in HIT, and clinical relevance.
    Rollin J, Charuel N, Gruel Y, Billy S, Guéry EA, May MA, Pouplard C, Vayne C.
    J Thromb Haemost; 2022 Nov 09; 20(11):2646-2655. PubMed ID: 35971886
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.